155 related articles for article (PubMed ID: 326202)
1. [Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].
Fritz J; Grond K
Arch Dermatol Res (1975); 1977 Apr; 258(2):121-6. PubMed ID: 326202
[TBL] [Abstract][Full Text] [Related]
2. [Cellular immunity in melanomalignome (author's transl)].
Fritz J; Grond K; Tilz GP
Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
[TBL] [Abstract][Full Text] [Related]
3. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
4. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
5. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
6. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests.
Kristensen E
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):449-53. PubMed ID: 6681340
[TBL] [Abstract][Full Text] [Related]
7. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676
[TBL] [Abstract][Full Text] [Related]
8. [Sensitization of lymphocyte to tumor extract detected by macrophage migration inhibition test(MIT) in patients with cervical cancer (author's transl)].
Ohno M
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):919-28. PubMed ID: 7240870
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of leucocyte migration by tumour-associated antigens of the colon and rectum.
Guillou PJ; Giles GR
Gut; 1973 Sep; 14(9):733-8. PubMed ID: 4201667
[TBL] [Abstract][Full Text] [Related]
10. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
11. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
Isbister WH
N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
[TBL] [Abstract][Full Text] [Related]
12. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
Lieberman R; Wybran J; Epstein W
Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
[TBL] [Abstract][Full Text] [Related]
13. [Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)].
Lischka G
Arch Dermatol Res (1975); 1975 Sep; 253(2):105-12. PubMed ID: 1190833
[TBL] [Abstract][Full Text] [Related]
14. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
Henderson WR; Fukuyama K; Epstein WL; Spitler LE
J Invest Dermatol; 1972 Apr; 58(4):229-32. PubMed ID: 5020976
[No Abstract] [Full Text] [Related]
16. Leukocyte migration inhibition by cancer patients' sera.
Cochran AJ; Mackie RM; Ross CE; Ogg LJ; Jackson AM
Int J Cancer; 1976 Sep; 18(3):274-81. PubMed ID: 1066319
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.
Bullen AW; Losowsky MS
Clin Exp Immunol; 1978 Mar; 31(3):408-13. PubMed ID: 350459
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
19. An immunological aspect of melanoma and its potential application in adjuvant therapy.
Elias EG; Tomazic VJ
J Surg Oncol; 1991 Dec; 48(4):220-3. PubMed ID: 1745045
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of cellular immunity in melanoma by means of a modified leukocyte migration inhibition test].
Bowszyc J; Bowszyc J; Wojnerowicz-Grajewska M; Milanowski L
Przegl Dermatol; 1980; 67(3):319-23. PubMed ID: 6968922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
